"The clinical trial approval obtained for the product marks the first significant achievement of the Group in the field of cell therapy," CSPC said in a stock exchange filing, referring to the approval by the China National Medical Products Administration.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/LYQMpqU
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment